Get the Stockscreener App
2.44
2.01%
-0.05
Revelation Biosciences Inc stock is traded at $2.44, with a volume of 84,191.
It is down -2.01% in the last 24 hours and up +197.56% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$2.49
Open:
$2.45
24h Volume:
84,191
Relative Volume:
0.08
Market Cap:
$3.82M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.1313
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-15.28%
1M Performance:
+197.56%
6M Performance:
-35.28%
1Y Performance:
-89.70%
1-Day Range:
$2.38
$2.48
1-Week Range:
$2.31
$2.91
52-Week Range:
$0.702
$56.00
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
2.44 | 3.82M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Stock (REVB) Latest News
Revelation Biosciences Inc. Shows Risk Reward Favoring UpsideOptimized Watchlist With Daily Adjustments Launched - metal.it
When is Revelation Biosciences Inc. stock expected to show significant growth - jammulinksnews.com
What are the latest earnings results for Revelation Biosciences Inc.Swing Trade Report For Consistent Profits - jammulinksnews.com
What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higher in 2025AI Powered Tracker That Work - jammulinksnews.com
When is Revelation Biosciences Inc. Equity Warrant stock expected to show significant growth - jammulinksnews.com
Can volume confirm reversal in Revelation Biosciences Inc. Equity WarrantAutomated AI Forecast with Trading Alerts - Newser
How Revelation Biosciences Inc. Equity Warrant stock performs during market volatilityFree Sector Rotation Based Trading Opportunities - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc. Equity WarrantHigh Conviction Intraday Stock Signals Detected - metal.it
Will earnings trigger a reversal in Revelation Biosciences Inc. Equity WarrantTechnical Setup and Return Forecast Engine - Newser
Why Revelation Biosciences Inc. Equity Warrant stock attracts strong analyst attentionSafe Entry Screening with Data Backed Analysis - Newser
Real Time Chart Alerts Flash Bullish on Revelation Biosciences Inc.Fast Gaining Stock Screener Reports Released - metal.it
Earnings Chart Overlay Points to Revelation Biosciences Inc. UpsideDaily Smart Money Movement Monitor Activated - metal.it
What MACD signals say about Revelation Biosciences Inc. Equity WarrantRisk Aware Trading Ideas with Alert Levels - Newser
What makes Revelation Biosciences Inc. stock price move sharplyMarket Forecast Summary Over Multi-Year Period - Newser
Published on: 2025-07-29 22:24:15 - metal.it
What institutional investors are buying Revelation Biosciences Inc. stockFinancial News Forecasts For Smart Trading - jammulinksnews.com
Why is Revelation Biosciences Inc. stock attracting strong analyst attentionJaw-dropping returns - jammulinksnews.com
How does Revelation Biosciences Inc. Equity Warrant generate profit in a changing economyAdvanced Screener Data Feed To Watch Now - jammulinksnews.com
Published on: 2025-07-28 15:09:14 - metal.it
How Revelation Biosciences Inc. stock performs during market volatilityFree Daily Stock Market Swing Alerts - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc.Chart Scanner for Swing Trade Timing - Newser
How Revelation Biosciences Inc. stock performs during market volatility Trading Volume Spike and Reversal Analysis - Newser
What catalysts could drive Revelation Biosciences Inc. stock higher in 2025Tap into rapid wealth building techniques - jammulinksnews.com
How does Revelation Biosciences Inc. Equity Warrant compare to its industry peersMarket Forecast Insights For 2025 - jammulinksnews.com
What is the dividend policy of Revelation Biosciences Inc. Equity Warrant stockExplosive portfolio gains - jammulinksnews.com
Does Revelation Biosciences Inc. stock perform well during market downturnsConsistent double returns - jammulinksnews.com
What makes Revelation Biosciences Inc. Equity Warrant stock price move sharplyDaily Equity Signal Strength Summary Report - Newser
Is Revelation Biosciences Inc. Equity Warrant a growth stock or a value stockAchieve exceptional returns with expert guidance - jammulinksnews.com
Is Revelation Biosciences Inc. Equity Warrant stock overvalued or undervaluedBuild wealth faster with disciplined trading - jammulinksnews.com
What are Revelation Biosciences Inc. Equity Warrant company’s key revenue driversAccelerated capital growth - jammulinksnews.com
What are the technical indicators suggesting about Revelation Biosciences Inc.Achieve breakthrough results with expert guidance - jammulinksnews.com
Revelation Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Exclusive Access to Stock Gurus - metal.it
Why is Revelation Biosciences Inc. Equity Warrant stock attracting strong analyst attentionRapid capital growth - jammulinksnews.com
What are the technical indicators suggesting about Revelation Biosciences Inc. Equity WarrantInvest smarter with expert stock picks - jammulinksnews.com
How volatile is Revelation Biosciences Inc. Equity Warrant stock compared to the marketCapitalize on emerging investment opportunities - jammulinksnews.com
Buy Signal for Revelation Biosciences Inc. Equity Warrant Stock Key Technical Indicators to WatchPredictable High Return Trades - metal.it
Will Revelation Biosciences Inc. Stock Benefit from AI and Green Energy TrendsFree Capital Growth Strategies - Newser
When is the best time to buy REVB stockCapital Safe Stock Watchlist - Newser
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):